(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.4% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 12.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.18%.
Envista Holdings's revenue in 2026 is $2,719,500,000.On average, 16 Wall Street analysts forecast NVST's revenue for 2026 to be $458,195,610,012, with the lowest NVST revenue forecast at $434,105,926,653, and the highest NVST revenue forecast at $480,974,290,195. On average, 14 Wall Street analysts forecast NVST's revenue for 2027 to be $474,419,274,315, with the lowest NVST revenue forecast at $450,821,217,147, and the highest NVST revenue forecast at $500,475,462,438.
In 2028, NVST is forecast to generate $494,248,197,352 in revenue, with the lowest revenue forecast at $468,519,760,023 and the highest revenue forecast at $515,715,874,359.